Alterations in macrophages and monocytes from tumor-bearing mice: Evidence of local and systemic immune impairment

Immunologic Research

Volumn 57, Issue 1-3, 2013, Pages 86-98

  Torroella Kouri, Marta ^a   Rodríguez, Dayron ^a,b   Caso, Raul ^a,c  

^a UNIVERSITY OF MIAMI   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunosuppression; Inflammation; Peritoneal and tumor associated macrophages; Tumorigenesis

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 11; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; BONE MARROW; BREAST TUMOR; CANCER GROWTH; CARCINOGENESIS; DOWN REGULATION; HOMEOSTASIS; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; MACROPHAGE FUNCTION; MONOCYTE; MYELOPOIESIS; NONHUMAN; PERITONEUM MACROPHAGE; POLARIZATION; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

ANIMALS; APOPTOSIS; BONE MARROW; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY, INNATE; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MONOCYTES; MYELOPOIESIS; NEOPLASM STAGING; NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 84891487969     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8438-3     Document Type: Article

References (77)

1. Elgert KD, Alleva DG, Mullins DW. Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol. 1998;64(3):275-90.
2. Gordon S the macrophage: past, present and future. Eur J Immunol. 2007;37(Suppl 1):S9-17. doi: 10.1002/eji.200737638.
3. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12):953-64. doi: 10.1038/nri1733.
4. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ. 2008;15(2):243-50. doi: 10.1038/sj.cdd.4402184.
5. Henson PM, Hume DA. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 2006;27(5):244-50. doi: 10.1016/j.it.2006.03.005.
6. Uderhardt S, Herrmann M, Oskolkova OV, Aschermann S, Bicker W, Ipseiz N, et al. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity. 2012;36(5):834-46. doi: 10.1016/j.immuni.2012.03.010.
7. Lichanska AM, Browne CM, Henkel GW, Murphy KM, Ostrowski MC, McKercher SR, et al. Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU.1. Blood. 1999;94(1):127-38.
8. Rae F, Woods K, Sasmono T, Campanale N, Taylor D, Ovchinnikov DA, et al. Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Dev Biol. 2007;308(1):232-46. doi: 10.1016/j.ydbio.2007.05.027.
9. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol. 2013;14(10):986-95. doi: 10.1038/ni.2705.
10. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol. 2009;9(4):259-70. doi: 10.1038/nri2528.
11. Biswas SK, Chittezhath M, Shalova IN, Lim JY. Macrophage polarization and plasticity in health and disease. Immunol Res. 2012;53(1-3):11-24. doi: 10.1007/s12026-012-8291-9.
12. Butterfield TA, Best TM, Merrick MA the dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J Athl Train. 2006;41(4):457-65.
13. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958-69. doi: 10.1038/nri2448.
14. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Investig. 2012;122(3):787-95. doi: 10.1172/JCI59643.
15. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol. 2005;175(1):342-9.
16. Duan M, Li WC, Vlahos R, Maxwell MJ, Anderson GP, Hibbs ML. Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J Immunol. 2012;189(2):946-55. doi: 10.4049/jimmunol.1200660.
17. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32(5):593-604. doi: 10.1016/j.immuni.2010.05.007.
18. Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. 2013;. doi: 10.1007/s10456-013-9381-6.
19. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841-5. doi: 10.1126/science.1194637.
20. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012;336(6077):86-90. doi: 10.1126/science.1219179.
21. Davies LC, Rosas M, Smith PJ, Fraser DJ, Jones SA, Taylor PR. A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation. Eur J Immunol. 2011;41(8):2155-64. doi: 10.1002/eji.201141817.
22. Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, van Rooijen N, et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science. 2011;332(6035):1284-8. doi: 10.1126/science.1204351.
23. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23-35. doi: 10.1038/nri978.
24. Mosser DM the many faces of macrophage activation. J Leukoc Biol. 2003;73(2):209-12.
25. Schreiber RD. Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity. Contemp Top Immunobiol. 1984;13:171-98.
26. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23(11):549-55.
27. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Investig. 2007;117(1):175-84. doi: 10.1172/JCI29881.
28. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11(11):750-61. doi: 10.1038/nri3088.
29. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889-96. doi: 10.1038/ni.1937.
30. Stout RD, Watkins SK, Suttles J. Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J Leukoc Biol. 2009;86(5):1105-9. doi: 10.1189/jlb.0209073.
31. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol. 2004;76(3):509-13. doi: 10.1189/jlb.0504272.
32. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7(3):211-7. doi: 10.1016/j.ccr.2005.02.013.
33. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-44. doi: 10.1038/nature07205.
34. Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev. 2008;18(1):11-8. doi: 10.1016/j.gde.2007.12.007.
35. Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Investig. 2008;118(7):2516-25. doi: 10.1172/JCI35073.
36. Nowarski R, Gagliani N, Huber S, Flavell R. Innate immune cells in inflammation and cancer. Cancer Immunol Res. 2013;1(2):77-84.
37. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4(1):71-8. doi: 10.1038/nrc1256.
38. Bingle L, Brown NJ, Lewis CE the role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol. 2002;196(3):254-65. doi: 10.1002/path.1027.
39. Medrek C, Ponten F, Jirstrom K, Leandersson K the presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer. 2012;12:306. doi: 10.1186/1471-2407-12-306.
40. Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer. 2008;15(4):1069-74. doi: 10.1677/ERC-08-0036.
41. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66(2):605-12. doi: 10.1158/0008-5472.CAN-05- 4005.
42. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39-51. doi: 10.1016/j.cell.2010.03.014.
43. Medina D, DeOme KB. Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination. J Natl Cancer Inst. 1969;42(2):303-10.
44. Torroella-Kouri M, Ma X, Perry G, Ivanova M, Cejas PJ, Owen JL, et al. Diminished expression of transcription factors nuclear factor kappaB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice. Cancer Res. 2005;65(22):10578-84. doi: 10.1158/0008-5472.CAN-05-0365.
45. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749-59. doi: 10.1038/nri1703.
46. Torroella-Kouri M, Lopez DM. Mammary tumor-derived TGF-b1 impairs crucial innate immune responses in tumor hosts. J Immunol Immunopathol. 2003;5(1):31-8.
47. Torroella-Kouri M, Silvera R, Rodriguez D, Caso R, Shatry A, Opiela S, et al. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. Cancer Res. 2009;69(11):4800-9. doi: 10.1158/0008-5472.CAN-08-3427.
48. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol. 2004;4(12):941-52. doi: 10.1038/nri1498.
49. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Investig. 2007;117(5):1155-66. doi: 10.1172/JCI31422.
50. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162-74. doi: 10.1038/nri2506.
51. Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer. 2013;13(10):739-52. doi: 10.1038/nrc3581.
52. Ilkovitch D, Lopez DM. Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec. Blood. 2009;113(19):4729-39. doi: 10.1182/blood-2008-08-176438.
53. Torroella-Kouri M, Keith JC, Ivanova M, Lopez DM. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice. Int J Oncol. 2003;22(2):439-48.
54. Muscaritoli M, Bossola M, Battista Doglietto G, Rossi Fanelli F the ubiquitin/proteasome system in cancer cachexia. New Jersey: A Modern Approach Springer-Verlag; 2006.
55. Perry G, Iragavarapu-Charyulu V, Harhaj EW, Torroella-Kouri M. Role of the proteasome in the downregulation of transcription factors NFkappaB and C/EBP in macrophages from tumor hosts. Oncol Rep. 2010;23(3):875-81.
56. Wang T the 26S proteasome system in the signaling pathways of TGF-beta superfamily. Front Biosci. 2003;8:d1109-27.
57. Petrel TA, Brueggemeier RW. Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines. J Cell Biochem. 2003;88(1):181-90. doi: 10.1002/jcb.10353.
58. Rodriguez D, Silvera R, Carrio R, Nadji M, Caso R, Rodriguez G, et al. Tumor microenvironment profoundly modifies functional status of macrophages: peritoneal and tumor-associated macrophages are two very different subpopulations. Cell Immunol. 2013;283(1-2):51-60. doi: 10.1016/j.cellimm.2013. 06.008.
59. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci USA. 2009;106(35):14978-83. doi: 10.1073/pnas.0809784106.
60. Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, et al. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 2006;66(23):11432-40. doi: 10.1158/0008-5472.CAN-06-1867.
61. Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood. 2006;107(5):2112-22. doi: 10.1182/blood-2005-01-0428.
62. Kusmartsev S, Gabrilovich DI. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J Immunol. 2005;174(8):4880-91.
63. Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T, et al. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell. 2009;15(2):114-23. doi: 10.1016/j.ccr.2008.12. 018.
64. Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, et al. Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells. Cancer Res. 2012;72(11):2757-67. doi: 10.1158/0008-5472.CAN-11-3379.
65. Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Regulatory T cells in cancer. Adv Cancer Res. 2010;107:57-117. doi: 10.1016/S0065-230X(10)07003-X.
66. Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med. 2009;206(7):1457-64. doi: 10.1084/jem.20090207.
67. Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol. 2009;50(5):980-9. doi: 10.1016/j.jhep.2008.12.033.
68. Blatner NR, Bonertz A, Beckhove P, Cheon EC, Krantz SB, Strouch M, et al. In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proc Natl Acad Sci USA. 2010;107(14):6430-5. doi: 10.1073/pnas.0913683107.
69. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669-92. doi: 10.1146/annurev.immunol.021908.132557.
70. Geissmann F, Auffray C, Palframan R, Wirrig C, Ciocca A, Campisi L, et al. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol. 2008;86(5):398-408. doi: 10.1038/icb.2008.19.
71. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71-82.
72. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327(5966):656-61. doi: 10.1126/science.1178331.
73. Strauss-Ayali D, Conrad SM, Mosser DM. Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol. 2007;82(2):244-52. doi: 10.1189/jlb.0307191.
74. Yona S, Jung S. Monocytes: subsets, origins, fates and functions. Curr Opin Hematol. 2010;17(1):53-9. doi: 10.1097/MOH.0b013e3283324f80.
75. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 2005;8(3):211-26. doi: 10.1016/j.ccr.2005.08.002.
76. Caso R, Silvera R, Carrio R, Iragavarapu-Charyulu V, Gonzalez-Perez RR, Torroella-Kouri M. Blood monocytes from mammary tumor-bearing mice: early targets of tumor-induced immune suppression? Int J Oncol. 2010;37(4):891-900.
77. Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010;70(14):5728-39. doi: 10.1158/0008-5472.CAN-09-4672.